Gut Microbiota as Therapeutic Targets in Diabetes Management: Opportunities and Challenges

  • Anand Hinduja Consultant Physician, Aarti Clinic, Kharghar, Navi Mumbai, Maharashtra, India.
  • Ashish Pandya Lead Customer Success, Virtus Nutrition Pvt Ltd, India.
  • Nidhi Chheda Product Lead, Virtus Nutrition Pvt Ltd, India.
Keywords: Type 2 Diabetes mellitus, Gut microbiota, Diet, Probiotics, Prebiotics, Synbiotics and Postbiotics, Gut microbes, Metabolic pathways

Abstract

This article delves into the complex interplay between Type 2 Diabetes Mellitus (T2DM), gut microbiota, and dietary strategies for effective diabetes management. T2DM, characterized by insulin resistance and β-cell dysfunction, is influenced by genetic and environmental factors. The gut-brain axis and alterations in incretin functioning contribute to gastrointestinal permeability in T2DM. Plant-based diets offer substantial benefits for managing T2DM by improving emotional well-being, HbA1c levels, weight, and cholesterol. High-fiber diets positively impact gut microbiota, serum metabolism, and emotional health in T2DM individuals. Probiotics, prebiotics, synbiotics, and postbiotics (PPSP) are emerging as pivotal interventions. Probiotics improve serum fructosamine, HbA1c, and cholesterol levels, while prebiotics like oligofructose-enriched inulin and synbiotics enhance glycemic control and lipid profiles. Insights from microbiome studies in diverse dietary populations provide personalized approaches for diabetes management. Integrating plant-based nutrition, PPSP interventions, and microbiome-focused strategies may offer a comprehensive and effective approach to T2DM management, addressing physiological aspects and empowering individuals in their health journey.

Published
2024-05-20